London Daily

Focus on the big picture.
Tuesday, Oct 07, 2025

Covid-19: UK setting up vaccine centres ready for rollout

Covid-19: UK setting up vaccine centres ready for rollout

The NHS is setting up coronavirus vaccination centres across the UK in preparation for any jab being approved, Health Secretary Matt Hancock has said.

People will be vaccinated at sites around the country, as well as in hospitals and by GPs in the community.

The government has also officially asked the medical regulator to assess the Pfizer-BioNTech vaccine.

Mr Hancock said if the regulator approved it, vaccination could start next month.

But the bulk of the vaccination rollout would be in the new year, he added.

It comes as another 20,252 confirmed Covid cases were announced by the government on Friday, as well as a further 511 deaths.

Speaking at the Downing Street briefing, Mr Hancock said: "The NHS is in the process of establishing vaccination centres across the country that can manage the logistical challenge of needing to store the Pfizer-BioNTech vaccine at -70C.

"In addition it is establishing vaccination hubs in hospitals for NHS staff.

"These two routes are likely to comprise the bulk of the campaign this side of the new year. Then there will be a community rollout involving GPs and pharmacists."

Vaccination centres could be set up in places like sports halls, and earlier this week it was confirmed that a sports arena in Derby had been earmarked to be used.

On the question of when people could get vaccinated, Mr Hancock said: "I know everyone wants to know about the timing and the speed of the rollout. That will depend on the speed at which the vaccines can be manufactured.

"We know that the manufacturing process for all vaccines is difficult and uncertain so I've asked the NHS to be ready to deploy at the speed at which the vaccine can be produced.

"If, and it still is an if, if the regulator approves a vaccine, we will be ready to start the vaccination next month with the bulk of the rollout in the new year. We're heading in the right direction but there is still a long way to go."

Mr Hancock also confirmed the government had formally asked the independent medical regulator - the Medicines and Healthcare products Regulatory Agency - to assess the Pfizer-BioNTech vaccine.

He said the UK government had been given the "confidence" to begin the process, after the vaccine-makers applied for approval in the US.

Three vaccines - Pfizer/BioNTech, Sputnik and Moderna - have already reported good early results from the final stages of testing, called phase-three trials.

The first breakthrough came from the Pfizer-BioNTech vaccine, which published data first and showed it protected 94% of adults over 65.

Another vaccine, developed by Oxford University and AstraZeneca, has shown positive results at an earlier stage, phase two.

The UK government has ordered more doses of the Oxford vaccine than any other (100 million doses) - but has also ordered 40 million doses of the Pfizer-BioNTech vaccine and five million of the Moderna vaccine.



The NHS Confederation, which represents NHS bosses, said the vaccine offered "a glimmer of hope but it won't save the NHS this Christmas".

"When the national restrictions are lifted in two weeks' time, life cannot go back to normal and they will have to be replaced with measures that protect the NHS from becoming overwhelmed," it said.

Asked about Christmas and whether Covid restrictions could be relaxed, Mr Hancock said the government was still working to decide what should happen after England's lockdown ends on 2 December.

"It's still too early to tell, although we can see from the data out in the last couple of days, and also from the ONS survey out today, that this is clearly flattening," he said. "We're clearly near the peak of this second increase and the second wave."

NHS England's medical director Prof Stephen Powis also said it appeared the number of hospital patients with coronavirus had been "levelling off" in the last few days.

But he added: "That is just a few days' data and it's important not to read too much into it yet."

It comes as the government's group of scientific advisers said the R rate - the number of people on average that one infected person passes the virus onto - had dropped to between 1 and 1.1 for the UK as a whole.



Mr Hancock also urged people aged 50 and over to get a flu jab.

Thirty million people are being offered a flu jab in England's largest flu-immunisation scheme to date. People aged 50 to 64 will be eligible for the vaccine from 1 December.


Health Secretary Matt Hancock: "We will be ready to start vaccination next month"


Newsletter

Related Articles

0:00
0:00
Close
Three Scientists Awarded Nobel Prize in Medicine for Discovery of Immune Self-Tolerance Mechanism
OpenAI and AMD Forge Landmark AI-Chip Alliance with Equity Option
Munich Airport Reopens After Second Drone Shutdown
France Names New Government Amid Political Crisis
Trump Stands Firm in Shutdown Showdown and Declares War on Drug Cartels — Turning Crisis into Opportunity
Surge of U.S. Billionaires Transforms London’s Peninsula Apartments into Ultra-Luxury Stronghold
Pro Europe and Anti-War Babiš Poised to Return to Power After Czech Parliamentary Vote
Jeff Bezos Calls AI Surge a ‘Good’ Bubble, Urges Focus on Lasting Innovation
Japan’s Ruling Party Chooses Sanae Takaichi, Clearing Path to First Female Prime Minister
Sean ‘Diddy’ Combs Sentenced to Fifty Months in Prison Following Prostitution Conviction
Taylor Swift’s ‘Showgirl’ Launch Extends Billion-Dollar Empire
Trump Administration Launches “TrumpRx” Plan to Enable Direct Drug Sales at Deep Discounts
Trump Announces Intention to Impose 100 Percent Tariff on Foreign-Made Films
Altman Says GPT-5 Already Outpaces Him, Warns AI Could Automate 40% of Work
Singapore and Hong Kong Vie to Dominate Asia’s Rising Gold Trade
Trump Organization Teams with Saudi Developer on $1 Billion Trump Plaza in Jeddah
Manhattan Sees Surge in Office-to-Housing Conversions, Highest Since 2008
Switzerland and U.S. Issue Joint Assurance Against Currency Manipulation
Electronic Arts to Be Taken Private in Historic $55 Billion Buyout
Thomas Jacob Sanford Named as Suspect in Deadly Michigan Church Shooting and Arson
Russian Research Vessel 'Yantar' Tracked Mapping Europe’s Subsea Cables, Raising Security Alarms
New York Man Arrested After On-Air Confession to 2017 Parents’ Murders
U.S. Defense Chief Orders Sudden Summit of Hundreds of Generals and Admirals
Global Cruise Industry Posts Dramatic Comeback with 34.6 Million Passengers in 2024
Trump Claims FBI Planted 274 Agents at Capitol Riot, Citing Unverified Reports
India: Internet Suspended in Bareilly Amid Communal Clashes Between Muslims and Hindus
Supreme Court Extends Freeze on Nearly $5 Billion in U.S. Foreign Aid at Trump’s Request
Archaeologists Recover Statues and Temples from 2,000-Year-Old Sunken City off Alexandria
China Deploys 2,000 Workers to Spain to Build Major EV Battery Factory, Raising European Dependence
Speed Takes Over: How Drive-Through Coffee Chains Are Rewriting U.S. Coffee Culture
U.S. Demands Brussels Scrutinize Digital Rules to Prevent Bias Against American Tech
Ringo Starr Champions Enduring Beatles Legacy While Debuting Las Vegas Art Show
Private Equity’s Fundraising Surge Triggers Concern of European Market Shake-Out
Colombian President Petro Vows to Mobilize Volunteers for Gaza and Joins List of Fighters
FBI Removes Agents Who Kneeled at 2020 Protest, Citing Breach of Professional Conduct
Trump Alleges ‘Triple Sabotage’ at United Nations After Escalator and Teleprompter Failures
Shock in France: 5 Years in Prison for Former President Nicolas Sarkozy
Tokyo’s Jimbōchō Named World’s Coolest Neighbourhood for 2025
European Officials Fear Trump May Shift Blame for Ukraine War onto EU
BNP Paribas Abandons Ban on 'Controversial Weapons' Financing Amid Europe’s Defence Push
Typhoon Ragasa Leaves Trail of Destruction Across East Asia Before Making Landfall in China
The Personality Rights Challenge in India’s AI Era
Big Banks Rebuild in Hong Kong as Deal Volume Surges
Italy Considers Freezing Retirement Age at 67 to Avert Scheduled Hike
Italian City to Impose Tax on Visiting Dogs Starting in 2026
Arnault Denounces Proposed Wealth Tax as Threat to French Economy
Study Finds No Safe Level of Alcohol for Dementia Risk
Denmark Investigates Drone Incursion, Does Not Rule Out Russian Involvement
Lilly CEO Warns UK Is ‘Worst Country in Europe’ for Drug Prices, Pulls Back Investment
Nigel Farage Emerges as Central Force in British Politics with Reform UK Surge
×